This site is intended for healthcare professionals only
LoginRegister
CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease ApprovalsDrugs Committee seeks DGHS Opinion on Discontinuing Mercurochrome, Merbromin Topical Antiseptics
Serum Institutes Indigenous HPV Vaccine CERVAVAC Gets WHO Prequalification, Opens Way for UN ProcurementSerum Institute's Indigenous HPV Vaccine CERVAVAC Gets WHO Prequalification, Opens Way for UN...
Aurobindo Pharma Gets USFDA Nod for Epilepsy Drug Perampanel, Targets USD 67 Mn US MarketAurobindo Pharma Gets USFDA Nod for Epilepsy Drug Perampanel, Targets USD 67 Mn US Market
Emcure Pharma Slapped With Rs 57.73 Cr Income-Tax Penalty for 7 Financial YearsEmcure Pharma Slapped With Rs 57.73 Cr Income-Tax Penalty for 7 Financial Years
Gland Pharma to Invest USD 21 Mn in US Expansion, Acquire 60% Stake in Novelstar PharmaGland Pharma to Invest USD 21 Mn in US Expansion, Acquire 60% Stake in Novelstar Pharma
Pharma Medical Representative Attacked, Robbed by 5 Men in JaipurPharma Medical Representative Attacked, Robbed by 5 Men in Jaipur
Centre Mulls Easing BA/BE Norms for Domestic Drug Approvals, CT-17 Timeline Cut to 45 DaysSummit, AstraZeneca and Daiichi Sankyo Plan Phase III Trial in Triple-Negative Breast Cancer
AstraZeneca Gets CDSCO Nod to Market Enhertu for New Breast Cancer IndicationAstraZeneca Gets CDSCO Panel Nod to Import, Market Camizestrant for Breast Cancer
Novartis Drops Experimental Amyotrophic Lateral Sclerosis Drug After Mid-Stage Trial FailureNovartis Signs Licensing Deal Worth Up to $7.8 Billion With Abogen for mRNA Therapies
Regeneron drug halves muscle lossRegeneron's Experimental Drug Shows Muscle-Preserving Benefit With Semaglutide
US FDA extends review of Novo Nordisks hemophilia drugUS FDA Extends Review of Novo Nordisk's Hemophilia Drug Amid Manufacturing Remediation
surprise inspection of hospitalsReactin Plus Violations: Maharashtra FDA Cancels Cipla Warehouse Licences
X